Calithera Biosciences, Inc.
CALA · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25 | $34 | $42 | $45 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $2 |
| Total Curr. Assets | $27 | $35 | $43 | $47 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $29 | $37 | $46 | $50 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $2 |
| Short-Term Debt | $2 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $6 | $0 | $0 |
| Other Curr. Liab. | $5 | $7 | $6 | $8 |
| Total Curr. Liab. | $7 | $9 | $9 | $11 |
| LT Debt | $0 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $0 | $41 |
| Total NC Liab. | $1 | $1 | $1 | $42 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $3 |
| Total Liabilities | $8 | $11 | $10 | $53 |
| Equity | – | – | – | – |
| Pref Stock | $22 | $22 | $22 | $41 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$513 | -$506 | -$496 | -$505 |
| AOCI | $0 | $0 | $0 | -$41 |
| Other Equity | $511 | $510 | $509 | $502 |
| Total Equity | $20 | $26 | $35 | -$3 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $29 | $37 | $46 | $50 |
| Net Debt | -$24 | -$32 | -$39 | -$42 |